Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian ...

In both clinical trials, lixudebart demonstrated a favorable safety profile, both as a monotherapy and in combination with standard of care (n=51 active patients across the two trials). These findings ...

Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer deaths worldwide. In 2023, ...

This manuscript offers valuable insights by identifying two distinct liver cancer subtypes through multi-omics integration and developing a robust prognostic model, validated across various datasets, ...

New research by Oregon Health & Science University scientists has uncovered multiple factors to improve gene delivery to the ...

PAX-1 is under clinical development by Komipharm International and currently in Phase I for Metastatic Melanoma.

PAX-1 is under clinical development by Komipharm International and currently in Phase I for Kidney Cancer (Renal Cell Cancer).

Pathology was obtained in five cases (four RCCs and one oncocytoma). No patients died of RCC or developed metastatic disease. [24] The studies on active surveillance that have been published to ...

The Eagles are a powerhouse and should be able to run the ball at will and cover this field-goal spread. Read our full Eagles vs. Commanders predictions. The Cardinals are good at beating up on ...